title: Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis.
abstract: OBJECT The aim of this study was to evaluate the effectiveness of antimicrobial-impregnated and -coated shunt catheters (antimicrobial catheters) in reducing the risk of infection in patients undergoing CSF shunting or ventricular drainage. METHODS The PubMed and Scopus databases were searched. Catheter implantation was classified as either shunting (mainly ventriculoperitoneal shunting) or ventricular drainage (mainly external [EVD]). Studies evaluating antibioticimpregnated catheters (AICs), silver-coated catheters (SCCs), and hydrogel-coated catheters (HCCs) were included. A random effects model meta-analysis was performed. RESULTS Thirty-six studies (7 randomized and 29 nonrandomized, 16,796 procedures) were included. The majority of data derive from studies on the effectiveness of AICs, followed by studies on the effectiveness of SCCs. Statistical heterogeneity was observed in several analyses. Antimicrobial shunt catheters (AICs, SCCs) were associated with lower risk for CSF catheter-associated infections than conventional catheters (CCs) (RR 0.44, 95% CI 0.35-0.56). Fewer infections developed in the patients treated with antimicrobial catheters regardless of randomization, number of participating centers, funding, shunting or ventricular drainage, definition of infections, de novo implantation, and rate of infections in the study. There was no difference regarding gram-positive bacteria, all staphylococci, coagulase-negative streptococci, and Staphylococcus aureus, when analyzed separately. On the contrary, the risk for methicillin-resistant S. aureus (MRSA, RR 2.64, 95% CI 1.26-5.51), nonstaphylococcal (RR 1.75, 95% CI 1.22-2.52), and gram-negative bacterial (RR 2.13, 95% CI 1.33-3.43) infections increased with antimicrobial shunt catheters. CONCLUSIONS Based on data mainly from nonrandomized studies, AICs and SCCs reduce the risk for infection in patients undergoing CSF shunting. Future studies should evaluate the higher risk for MRSA and gram-negative infections. Additional trials are needed to investigate the comparative effectiveness of the different types of antimicrobial catheters.
authors.affiliation: Alfa Institute of Biomedical Sciences;
authors.forename: Athanasios A
authors.initials: AA
authors.lastname: Konstantelias
authors.forename: Konstantinos Z
authors.initials: KZ
authors.lastname: Vardakas
authors.forename: Konstantinos A
authors.initials: KA
authors.lastname: Polyzos
authors.forename: Giannoula S
authors.initials: GS
authors.lastname: Tansarli
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Falagas
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage*; D055499:Catheter-Related Infections / Q000517:prevention & control*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002557:Cerebrospinal Fluid Shunts / Q000295:instrumentation*; D004322:Drainage / Q000295:instrumentation*; D004337:Drug Carriers; D004867:Equipment Design; D006801:Humans; D006849:Hydrocephalus / Q000601:surgery*
chemical_list: D000890:Anti-Infective Agents; D004337:Drug Carriers
keywords: AIC = antibiotic-impregnated catheter; CC = conventional catheter; CSF = cerebrospinal fluid; CoNS = coagulase-negative streptococci; EVD = external ventricular drainage; HCC = hydrogel-coated catheter; MRSA = methicillin-resistant Staphylococcus aureus; RCT = randomized controlled trial; SCC = silver-coated catheter; antibiotic-impregnated catheters; cerebrospinal shunt; external ventricular drainage; hydrocephalus; hydrogel-catheters; infection; silver-coated shunt; ventriculoperitoneal shunt